Procter & Gamble Company - Skin Care Composition Patent US12599548B2
Summary
The USPTO granted Patent US12599548B2 to The Procter & Gamble Company for a method of treating oxidative stress in skin using a composition containing a sucrose ester and fatty alcohol at a specific ratio. The patent was granted with 12 claims. Inventors include Tomohiro Hakozaki, Leo Timothy Laughlin II, Matthew Clair Ehrman, and XiPing Ng.
What changed
The USPTO granted Patent US12599548B2 to The Procter & Gamble Company on April 14, 2026. The patent covers a method of treating oxidative stress in skin using a composition containing a sucrose ester and a fatty alcohol at a specific ratio to provide synergistic improvement in cellular ATP levels. The patent includes 12 claims and was based on Application No. 18732895.
For competitors in the skin care and cosmetics industry, this patent establishes intellectual property protection around a specific formulation approach for addressing oxidative stress in skin cells. Companies developing similar compositions or formulations should review the patent claims to assess potential freedom-to-operate concerns or licensing opportunities.
What to do next
- Monitor competitive landscape for similar patents
- Review patent claims for potential licensing opportunities
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method of treating oxidative stress in skin and compositions therefor
Grant US12599548B2 Kind: B2 Apr 14, 2026
Assignee
The Procter & Gamble Company
Inventors
Tomohiro Hakozaki, Leo Timothy Laughlin, II, Matthew Clair Ehrman, XiPing Ng
Abstract
Cellular energy levels in skin cells affected by oxidative stress can be improved through the use of a skin care composition that includes a sucrose ester and a fatty alcohol present at a specific ratio. The fatty alcohol and sucrose ester, when incorporated into a skin care composition at a specific ratio, can provide a synergistic improvement in cellular ATP level for skin cells suffering from the effects of oxidative stress.
CPC Classifications
A61K 8/604 A61Q 19/08
Filing Date
2024-06-04
Application No.
18732895
Claims
12
Related changes
Get daily alerts for USPTO Patent Grants - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.